Clinical Trials
386 trialsCollection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
National Institutes of Health Clinical Center (CC)
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
Fox Chase Cancer Center
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
National Institutes of Health Clinical Center (CC)
Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging
Oslo University Hospital
OvAR-Y
Washington University School of Medicine
T1G3R-1 Trial: Detectability and Prognostic Value of ctDNA in T1 G3 Bladder Cancer
University Hospital, Basel, Switzerland
Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
Lanzhou University Second Hospital
A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
Astellas Pharma Inc
CISTO
University of Washington
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Istituto Oncologico Veneto IRCCS
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
iCaRe2
University of Nebraska
SR-ULM BC
Duke University
Evaluation for NCI Surgery Branch Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
DP-04
AstraZeneca
TVNIM-AFU
Association Francaise d'Urologie
ELEPHAS-02
Elephas
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Early is Good Inc.
Study on the Effects of Drugs That Modulate the Endocannabinoid System on Spontaneous and Induced Contractility of the Human Detrusor Muscle
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
CISTO2
University of Washington
Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment
AstraZeneca
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Mayo Clinic
Measuring Surgical Recovery After Radical Cystectomy
M.D. Anderson Cancer Center
Tumor Budding and T1 Substaging in Urothelial Bladder Cancer
Assiut University
TraveraRTGx
Travera Inc
Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer
Assiut University
BladMetrix
Oslo University Hospital
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
Determinants of Bladder Cancer Recurrence Study (The DETER Study)
Memorial Sloan Kettering Cancer Center
Bladder EpiCheck Product Development Study
Nucleix Ltd.
Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
National Institutes of Health Clinical Center (CC)
AVENANCE
Pfizer
ENAiBLE
Photocure
Outcomes of Definitive Radiotherapy for Bladder Cancer
Sohag University
(CLOCS-2)
Imperial College London
METRICS
University of Kansas Medical Center
MicroBlad
University Hospital, Toulouse
VISIOCYT2
Institut Paoli-Calmettes
ORI-EGI-03
Origin Sciences
Bladder Bank (a Prospective Banking Study)
Mayo Clinic
UroDNA
Institut Cancerologie de l'Ouest
GUB-BCR-001
University of Kansas Medical Center
Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
Mayo Clinic
MOMENTUM
UMC Utrecht
CONQUER
Aarhus University Hospital
GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit
Aarhus University Hospital
OCCURORTW
Jagiellonian University
The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer
Tianjin Medical University Second Hospital